A Comparative Study on The Therapeutic Effect of pH, Temperature Triggered, and Ion Activated In Situ Gelling System For Ocular Delivery

Insan Sunan Kurniawansyah, Insi Farisa Desy Arya, Arif Budiman, and Zubaidah

Abstract

One of the most popular pharmaceutical preparations for the eyes today is in situ gel. The in situ gel system is a system that is liquid at room temperature but will form a gel when it comes into contact with the body or undergoes a change in pH. The form of the drug delivery system is in-situ is a type of mucoadhesive drug delivery system. Gel formation depends on several factors such as temperature modulation, pH changes, the presence of ions, ultra-violet irradiation, electrical sensitivity, and the enzyme by which the active substance is released. The purpose of this study is to compare the therapeutic efficacy of in situ gel medicines on pH, temperature triggered, and ion activated gelling systems. A drug in situ gel is a drug delivery device that transforms into a gel after being applied to the body. The findings revealed that the pH, temperature triggered, and ion activated gelling system factors had a substantial influence on the extended release medicines that affect the therapeutic effect of in situ gel medications. This comparative investigation demonstrates that the pH, temperature triggered, and ion activated gelling system factors have significant implications on the therapeutic benefits of in situ gelled medicines. A deeper knowledge of the relationships between these variables and in situ gel drug delivery methods can lead to the development of more effective and dependable medication compositions. These findings could aid in the development of improved gel in situ drug delivery systems to improve therapeutic benefits in the treatment of a variety of medical disorders. 

 

Keywords: in situ gel, pH triggered, temperature triggered, ion activated, therapeutic effect.

Full Text:

PDF

References

Agarwal KI, Metha N, Namdev A, Guptaa AK. In Situ Gel Formulation for Ocular Drug Delivery System an Overview. Asian Journal of Biomedical and Pharmaceutical Sciences. 2011. 1(4): 1-7.

Gupta A and Manocha N. Formulation and Evaluation of In Situ Ophthalmic Drug Delivery System. International Journal of Pharmaceutical & Biological Archives. 2012. 3(4): 715-718.

Jain S, Jain P, Mishra A, Pathak A. A Review on Triggered Gel for Ocular Delivery. International Journal of Pharmaceutical & Biological Archives. 2014. 5(4): 19-25.

Mandal S, Thimmasetty MKMJ, Prabhushankar GL, Getha MS. 2017. Formulation and Evaluation of an In Situ Gel-forming Ophthalmic Formulation of Moxifloxacin Hydrochloride. International Journal of Pharmaceutical Investigation. 2017. 2(2):78-82.

Pasquale and Wiggs. Genetics of glaucoma. Hum Mol Genet. 2017. 1(26):21-27.

Sayed EG, Hussein AK, Khaled KA, Ahmed OAA. 2015. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery. Dovepress. 2015. 9: 1427-1435. doi:10.2147/DDDT.S80697.

Sethuraman N, Balu A, Selvaraj R, Johnson T, Seetharaman S. Formulation and Characterization of pH Based Stimuli Sensitive Based Hydrogels for the Treatment of Ocular Infection. J. Young Pharm. 2018. 10(1):32-36.

Shashank NN, Bharani SS, Tahur RS. Formulation and Evaluation of pH Triggered In Situ Opthalmic Gel of Moxifloxacin Hydrochloride. International Journal of Pharmacy and Pharmaceutical Sciences. 2012. 4(2):452-459.

Sundari PJP, Maddela R, Srinivas P. Formulation and Evaluation of Thermosensitive Ocular In Situ Gels For Sustained Release of Balofloxacin. World Journal of Pharmacy and Pharmaceutical Sciences. 2015. 4(11): 835-845.

Verma L, Sakir M, Singh N, Gilhotra RM, Mehan S. Development of Phase Change Solutions For Ophthalmic Drug Delivery Based on Ion Activated and pH Induced Polymers. International Journal of Pharma Professional’s Research. 2010. 1(2): 127-134.

Vodithala S, Khatry S, Shastri N, Sadanandam M. Formulation and Evaluation of Ion Activated Ocular Gels of Ketorolac Tromethamine. International Journal of Current Pharmaceutical Research. 2010. 2(3): 33-38.

Refbacks

  • There are currently no refbacks.